Engineering and Development

SVP, Commercial Strategy

Chief Technical Officer

Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Akero Therapeutics, Inc. Announces Lancet Publication of the Phase 2b Harmony Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-Cirrhotic MASH

Akero Therapeutics Q2 Net Loss Widens

This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Senior Quality Assurance Representative

Akero Therapeutics is a clinical stage biopharmaceutical company focused on developing treatments for serious metabolic diseases. The Senior Quality Assurance Representative will provide strategic oversight for outsourced drug substance and product operations, ensuring compliance with global GMP requirements and quality agreements while serving as a key interface between internal and external stakeholders.

Sign up with Google

Sign in with Google